Institutional Partners:The Pharmacology Department is closely associated with other research centers, clinics and institutes on the UCLA campus. This enables us to probe deeper into related fields as well as to collaborate to solve tenacious problems in our own field.
Crump Institute for Molecular Imaging
The Crump Institute is a multidisciplinary collaborative of scientists, students, and technologists. Researchers cross the imaginary barriers between physics, biology, chemistry, and computational sciences without resistance. This leads to a streamlined approach to exploration and discovery which unveils the totality of interdependant natural phenomena to the gaze of modern science.
California NanoSystems Institute
The California NanoSystems Institute (CNSI) is a research center at UCLA whose mission is to encourage university collaboration with industry and to enable the rapid commercialization of discoveries in nanosystems. CNSI members who are on the faculty at UCLA represent a multi-disciplinary team of some of the world's preeminent scientists. The work conducted at the CNSI represents world-class expertise in five targeted areas of nanosystems-related research including Renewable Energy; Environmental Nanotechnology and Nanotoxicology; NanoBiotechnology and Biomaterials; NanoMechanical and NanoFluidic systems; and NanoElectronics, Photonics and Architectonics.
Institute for Molecular Medicine
A new era of personalized medicine requires an unprecedented integration of many disciplines including chemistry, pathology, engineering, biology, physics, imaging and clinical sciences. Integration of these disciplines requires a new model of collaborative interaction between basic and clinical scientists with different backgrounds working together on common problems to an end result of proven benefit to patients. This “Team Science” focuses on problem-solving in patient care founded on new science and new technologies. The Institute for Molecular Medicine (IMED) is the coming together of these disciplines in a common space with a common mission – that is, to build the molecular tools for linking new molecular diagnostics and molecular therapeutics based on a new systems biology view of disease. The ultimate measure of success is in improving the care of patients.
Broad Stem Cell Research Center
The BSCRC is poised to be a leader in the field of stem cell biology and medicine by virtue of the $20 million commitment by UCLA and the close ongoing collaboration across the university’s scientific, medical and academic disciplines. The ISCBM will continue UCLA's strong history of translational research bringing research from the laboratory to the bedside, in breast, lung, and colon cancer, leukemia, and gene medicine.
The Ahmanson Biological Imaging Division is the clinical arm of the Pharmacology Department. They provide all aspects of diagnostic and therapeutic nuclear medicine services. Being part of a basic science department enables them to merge modern biology concepts with cutting edge imaging techniques. This allows the clinic to perform novel molecular imaging assays that are used in the drug discovery process as well as for cancer treatment monitoring in animals and humans.
Jonsson Comprehensive Cancer Center
UCLA's Jonsson Comprehensive Cancer Center (JCCC) has established an international reputation for developing new cancer therapies, providing the best in experimental and traditional treatments, and expertly guiding and training the next generation of medical researchers.
Ahmanson
Clinic